Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock
Catheterization and Cardiovascular Interventions2021Vol. 99(3), pp. 650–657
Citations Over TimeTop 10% of 2021 papers
Mir B. Basir, Alejandro Lemor, Sarah Gorgis, Angela M. Taylor, Behnam Tehrani, Alexander G. Truesdell, Aditya Bharadwaj, Brian Kolski, Kirit Patel, Joseph Gelormini, Josh Todd, David Lasorda, Craig Smith, Robert F. Riley, Steve Marso, Robert Federici, Navin K. Kapur, William W. O’Neill, The National Cardiogenic Shock Initiative Investigators
Abstract
Increasing vasopressor requirement is associated with increased mortality in AMICS independent of underlying CPO. Methods to decrease the need for vasopressors may enhance survival in AMICS.
Related Papers
- → Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature(2012)20 cited
- → Successful Combined Use of Impella Recover 2.5 Device and Intra-Aortic Balloon Pump Support in Cardiogenic Shock from Acute Myocardial Infarction(2010)20 cited
- → Percutaneous biventricular Impella support in therapy-refractory cardiogenic shock(2018)17 cited
- → Effective Mechanical Circulatory Support with Impella in Postcardiotomy Cardiogenic Shock(2017)1 cited
- → 312: First North American Experience with Microaxial Percutaneous LVAD for Severe Cardiogenic Shock(2009)1 cited